We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
10 Year Est. Return
AUM
$152M
AUM Growth
-$1.54M
Cap. Flow
+$1.94M
Cap. Flow %
1.28%
Top 10 Hldgs %
37.96%
Holding
86
New
25
Increased
15
Reduced
14
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 77.97%
2 Energy 0%

No holdings matched the selected filter criteria.

Similar funds

Iguana Healthcare Management's Q1 2018 Portfolio in Review

As of Q1 2018, Iguana Healthcare Management held 86 positions worth $152M, down 1% from $154M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Iguana Healthcare Management's Q1 2018 filing shows 25 new, 15 increased, 14 reduced and 24 closed positions. Its largest new stake was Zosano Pharma Corporation: 14,286 shares worth $2.52M. The largest sale was Celgene Corp, an estimated $7.83M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 82% a quarter earlier, followed by Energy.

  • Iguana Healthcare Management's largest Q1 2018 buy was Zosano Pharma Corporation: 14,286 shares worth $2.52M.
  • Iguana Healthcare Management added most to Arena Pharmaceuticals Inc in Q1 2018, an estimated $1.94M increase.
  • Iguana Healthcare Management's biggest Q1 2018 reduction was Esperion Therapeutics, cutting an estimated $4.77M.
  • Iguana Healthcare Management fully exited Celgene Corp in Q1 2018, selling an estimated $7.83M.
  • Iguana Healthcare Management's ten largest holdings make up 38% of its $152M portfolio in Q1 2018.
  • Iguana Healthcare Management opened 25 new positions and closed 24 in Q1 2018.
  • Iguana Healthcare Management's portfolio value fell 1% quarter-over-quarter to $152M.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.